» Articles » PMID: 23555184

Deconstruction of Medulloblastoma Cellular Heterogeneity Reveals Differences Between the Most Highly Invasive and Self-renewing Phenotypes

Overview
Journal Neoplasia
Publisher Elsevier
Specialty Oncology
Date 2013 Apr 5
PMID 23555184
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Medulloblastoma (MB) is the most common malignant primary pediatric brain tumor. Major research efforts have focused on characterizing and targeting putative brain tumor stem or propagating cell populations from the tumor mass. However, less is known about the relationship between these cells and highly invasive MB cells that evade current therapies. Here, we dissected MB cellular heterogeneity and directly compared invasion and self-renewal. Analysis of higher versus lower self-renewing tumor spheres and stationary versus migrating adherent MB cells revealed differential expression of the cell surface markers CD271 [p75 neurotrophin receptor (p75NTR)] and CD133. Cell sorting demonstrated that CD271 selects for subpopulations with a higher capacity for self-renewal, whereas CD133 selects for cells exhibiting increased invasion in vitro. CD271 expression is higher in human fetal cerebellum and primary samples of the Shh MB molecular variant and lower in the more aggressive, invasive group 3 and 4 subgroups. Global gene expression analysis of higher versus lower self-renewing MB tumor spheres revealed down-regulation of a cell movement transcription program in the higher self-renewing state and a novel potential role for axon guidance signaling in MB-propagating cells. We have identified a cell surface signature based on CD133/CD271 expression that selects for MB cells with a higher self-renewal potential or invasive capacity in vitro. Our study underscores a previously unappreciated role for CD271 in selecting for MB cell phenotypes and suggests that successful treatment of pediatric brain tumors requires concomitant targeting of a spectrum of transitioning self-renewing and highly infiltrative cell subpopulations.

Citing Articles

Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression.

Borlase S, DeCarlo A, Coudiere-Morrison L, Liang L, Porter C, Ramaswamy V Cell Death Discov. 2023; 9(1):347.

PMID: 37726268 PMC: 10509237. DOI: 10.1038/s41420-023-01646-0.


Metabolic determinants of stemness in medulloblastoma.

Martin-Rubio P, Espiau-Romera P, Royo-Garcia A, Caja L, Sancho P World J Stem Cells. 2022; 14(8):587-598.

PMID: 36157911 PMC: 9453267. DOI: 10.4252/wjsc.v14.i8.587.


Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression.

Zagozewski J, Borlase S, Guppy B, Coudiere-Morrison L, Shahriary G, Gordon V Commun Biol. 2022; 5(1):697.

PMID: 35835937 PMC: 9283517. DOI: 10.1038/s42003-022-03654-9.


Inhibiting ALK2/ALK3 Signaling to Differentiate and Chemo-Sensitize Medulloblastoma.

Filipponi D, Pagnuzzi-Boncompagni M, Pages G Cancers (Basel). 2022; 14(9).

PMID: 35565225 PMC: 9102092. DOI: 10.3390/cancers14092095.


The Roles of EphB2 in Cancer.

Liu W, Yu C, Li J, Fang J Front Cell Dev Biol. 2022; 10:788587.

PMID: 35223830 PMC: 8866850. DOI: 10.3389/fcell.2022.788587.


References
1.
Bao S, Wu Q, McLendon R, Hao Y, Shi Q, Hjelmeland A . Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444(7120):756-60. DOI: 10.1038/nature05236. View

2.
Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View

3.
Werbowetski-Ogilvie T, Seyed Sadr M, Jabado N, Angers-Loustau A, Agar N, Wu J . Inhibition of medulloblastoma cell invasion by Slit. Oncogene. 2006; 25(37):5103-12. PMC: 2072874. DOI: 10.1038/sj.onc.1209524. View

4.
Uchida N, Buck D, He D, Reitsma M, Masek M, Phan T . Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A. 2000; 97(26):14720-5. PMC: 18985. DOI: 10.1073/pnas.97.26.14720. View

5.
Molina J, Hayashi Y, Stephens C, Georgescu M . Invasive glioblastoma cells acquire stemness and increased Akt activation. Neoplasia. 2010; 12(6):453-63. PMC: 2887086. DOI: 10.1593/neo.10126. View